TSA vs RSA in Glenohumeral Osteoarthritis
Osteoarthritis of the ShoulderThis study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
65 and up
Critères de participation
Inclusion Criteria:
1. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:
1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
3. Activity modification
2. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
3. Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
4. 65 years of age and older
Exclusion Criteria:
1. Active joint or systemic infection
2. Rotator cuff arthropathy
3. Significant muscle paralysis
4. Charcot's arthropathy
5. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
6. Unable to understand the consent form/process
7. Pregnancy
8. Psychiatric illness that precludes informed consent
9. Unwilling to be followed for the duration of the study
10. Retroversion cannot be surgically corrected to within 10 degrees of neutral
11. History of previous shoulder surgery on affected side
Lieu de l'étude
University of Alberta
University of AlbertaEdmonton, Alberta
Canada
Contactez l'équipe d'étude
Martin Bouliane, MD
780-434-4859The Ottawa Hospital
The Ottawa HospitalOttawa, Ontario
Canada
Contactez l'équipe d'étude
Peter Lapner, MD
6137378899Pan Am Clinic Foundation
Pan Am Clinic FoundationWinnipeg, Manitoba
Canada
Contactez l'équipe d'étude
Sheila McRae
204-925-7469Kingston General Hospital (Site-Watkins 3)
Kingston General Hospital (Site-Watkins 3)Kingston, Ontario
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- Ottawa Hospital Research Institute
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT04228419